Related Experiment Video
Updated: Sep 16, 2025
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Rendering NK Cells Antigen-Specific for the Therapy of Solid Tumours
Carina A Doeppner1,2,3,4,5, Amanda Katharina Binder1,2,3,4,5, Franziska Bremm1,2,3,4,5
1Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, 91054 Erlangen, Germany.
Abstract:
Cancer remains one of the leading causes of death worldwide. New treatments like immunotherapy-especially checkpoint inhibitors and CAR-T cell therapy-have improved outcomes for some patients. However, these therapies often struggle to treat solid tumours effectively. Natural killer (NK) cells are part of the immune system and can naturally detect and destroy cancer cells without previous adaption. Scientists are now enhancing these cells by adding special receptors, called CARs (chimeric antigen receptors), to help them better recognize and attack cancer, an approach originally developed for T cells. CAR-NK cell therapy has some advantages over CAR-T therapy. It tends to cause fewer severe side effects, such as strong immune reactions or off-target effects in healthy tissues. Within some limitations, the allogenic use of CAR-NK cells is possible, as these cells exert less graft-versus-host activity. Such CAR-NK cell products can be produced in larger quantities and stored, making treatment more accessible. Still, there are challenges. It can be difficult to create enough modified NK cells, and the tumour microenvironment can block their activity. This review highlights recent progress in CAR-NK therapy, including early lab and clinical research. It also explores ways to improve these treatments and how they might work alongside other cancer therapies to help more patients in the future.
Insights
Chimeric antigen receptor Natural Killer (CAR-NK) cell therapy shows promise for treating solid tumors, offering potential advantages over CAR-T cell therapy with fewer side effects and broader applicability.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- Cancer is a leading global cause of death, with current immunotherapies like checkpoint inhibitors and CAR-T cell therapy showing limitations, especially against solid tumors.
- Natural Killer (NK) cells offer innate cancer-targeting capabilities.
- Chimeric antigen receptors (CARs) are engineered receptors that enhance immune cell recognition and killing of cancer cells.
Purpose of the Study:
- To review recent advancements in CAR-NK cell therapy for cancer treatment.
- To explore the potential advantages and challenges of CAR-NK cell therapy compared to existing treatments.
- To discuss strategies for improving CAR-NK cell efficacy and potential combination therapies.
Main Methods:
- Review of current scientific literature on CAR-NK cell therapy.
- Analysis of early laboratory and clinical research findings.
- Exploration of CAR engineering techniques for NK cells.
Main Results:
- CAR-NK cell therapy demonstrates potential for treating solid tumors, with early research showing promise.
- CAR-NK cells may offer improved safety profiles compared to CAR-T cells, including reduced severe immune reactions and off-target effects.
- Allogeneic CAR-NK cell applications are feasible, allowing for off-the-shelf products and greater accessibility.
Conclusions:
- CAR-NK cell therapy represents a promising advancement in cancer immunotherapy, particularly for solid tumors.
- Further research is needed to overcome challenges such as efficient CAR-NK cell production and overcoming the tumor microenvironment.
- CAR-NK cell therapy holds potential for integration with other cancer treatments to improve patient outcomes.
Related Concept Videos
01:27Tumor Immunotherapy
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...